Gilead outlines efforts to expand global supply of remdesivir for COVID-19

Remdesivir injection initially took nearly 1 year to manufacture. Gilead is in talks with chemical and pharmaceutical manufacturing companies around the world to work out voluntary licenses to produce remdesivir for Europe, Asia and the developing world through at least 2022.


Biospace Inc.